A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial design

By afschroeder • March 16, 2026

Ji J, Crespi CM, Yee L, Zekster YA, Al-Saleem A, Petersen L, Lee C, Son N, Smith C, Evans T, Tchkonia T, Kirkland JL, Kuchel GA, Cohen HJ, Sedrak MS. A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial design. Ther Adv Med Oncol. 2026 Mar 11;18:17588359261424668. doi: 10.1177/17588359261424668. PMID: 41835341; PMCID: PMC12979913.

Tags: breast cancer, chemotherapy, clinical trials, Fellow, Geriatric oncology, Geriatrics, Hematology/Oncology, novel therapiesl phase II trials, Publications, Quality of Life, survivorship, Veterans Administration

Experiential Avoidance is Associated with Insomnia Symptoms and Related Consequences Among Veterans with Posttraumatic Stress Disorder

Carlson GC, Gold AI, Erickson AJ, Kelly MR, Mitchell MN, Josephson KR, Carlson KJ, McGowan SK, MacCabe CHG, Zeidler MR, Fung CH, Alessi CA, Yano[...]

Unacylated Ghrelin Counteracts Mitochondrial Dysfunction and Neuromuscular Junction Disruption in Cancer Cachexia

Ahn B, Wanagat J, Cleary C, Ainsworth HC, Kim H. Unacylated Ghrelin Counteracts Mitochondrial Dysfunction and Neuromuscular Junction Disruption in Cancer Cachexia. Am J Physiol[...]

Colorectal Cancer and Mortality Risk Among Older Adults With vs Without Adenoma on Prior Colonoscopy

Gupta S, Liu L, Demb J, Qin J, Earles A, Lamm M, Huang X, Shah SC, Chawla N, Le Y, Loeb TB, Dominitz JA, Robertson[...]